Partners
Sunlight to feed the world
Photonics is an industry that has aroused Merck's curiosity for more than 30 years
Sharing -not competing- in the fight against Covid-19
Merck is accelerating development and production, and bringing resources and expertise to help identify effective and...
ORYZON receives the INNOVATIVE SME seal from the Ministry of Science and Innovation
Innovation present in Oryzon's programs in the field of epigenetics acknowledged. The company currently has 2 compounds...
MDR Literature Search
This article will focus on the Systematic Scientific Literature Search and Review as part of the Clinical Evaluation...
The National Spanish Hospital of Paraplegics and Merck collaborate in an international res...
This collaboration responds to the high quality of the research and scientific talent of the Hospital Nacional de...
Mirum Pharmaceuticals and Vivet Therapeutics Enter into Exclusive Worldwide Option and Lic...
Mirum expands potential opportunities across rare disease pipeline and Vivet will lead pre-clinical development of its...
Using cardio-metabolomic diagnosis to reduce the consequences of obesity
Biotech company OWL Metabolomics develops non-invasive, early diagnosis products for obesity-related diseases
ORYZON starts preclinical collaboration on autism with the Seaver Autism Center at Mount ...
Goal is to explore effects of LSD1 inhibition on animal models of autism in Shank3 deficient mice models
Our researcher in oncology, Gema Malet, receives a Marie Skłodowska-Curie research grant
In 2020, biologist Gema Malet Engra joined the biotechnology company Laminar Pharmaceuticals after a successful 15-year...
ORYZON enrolls first patient in PORTICO
PORTICO is a Phase IIb clinical trial with vafidemstat in Borderline Personality Disorder recruiting patients in Europe...